Precision medicine in rare diseases: What is next?
Molecular diagnostics is a cornerstone of modern precision medicine, broadly understood
as tailoring an individual's treatment, follow‐up, and care based on molecular data. In rare …
as tailoring an individual's treatment, follow‐up, and care based on molecular data. In rare …
PIK3CA-related overgrowth: silver bullets from the cancer arsenal?
Mutations that activate growth factor signaling often drive cancer growth. Many also arise in
isolation, causing developmental growth disorders. PIK3CA, that encodes a catalytic subunit …
isolation, causing developmental growth disorders. PIK3CA, that encodes a catalytic subunit …
PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption
S Ladraa, L Zerbib, C Bayard, A Fraissenon… - Science …, 2022 - science.org
PIK3CA-related overgrowth syndrome (PROS) is a genetic disorder caused by somatic
mosaic gain-of-function mutations of PIK3CA. Clinical presentation of patients is diverse and …
mosaic gain-of-function mutations of PIK3CA. Clinical presentation of patients is diverse and …
Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth
TL Wenger, S Ganti, C Bull, E Lutsky, JT Bennett… - Genetics in …, 2022 - Elsevier
Purpose PIK3CA-related overgrowth spectrum (PROS) conditions of the head and neck are
treatment challenges. Traditionally, these conditions require multiple invasive interventions …
treatment challenges. Traditionally, these conditions require multiple invasive interventions …
Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition
C Bayard, E Segna, M Taverne, A Fraissenon… - Journal of Experimental …, 2023 - rupress.org
Hemifacial myohyperplasia (HFMH) is a rare cause of facial asymmetry exclusively involving
facial muscles. The underlying cause and the mechanism of disease progression are …
facial muscles. The underlying cause and the mechanism of disease progression are …
When, where and which PIK3CA mutations are pathogenic in congenital disorders
A Angulo-Urarte, M Graupera - Nature Cardiovascular Research, 2022 - nature.com
PIK3CA encodes the class I PI3Kα isoform and is frequently mutated in cancer. Activating
mutations in PIK3CA also cause a range of congenital disorders featuring asymmetric tissue …
mutations in PIK3CA also cause a range of congenital disorders featuring asymmetric tissue …
[HTML][HTML] Vascular malformations: An overview of their molecular pathways, detection of mutational profiles and subsequent targets for drug therapy
A Mansur, I Radovanovic - Frontiers in Neurology, 2023 - frontiersin.org
Vascular malformations are anomalies in vascular development that portend a significant
risk of hemorrhage, morbidity and mortality. Conventional treatments with surgery …
risk of hemorrhage, morbidity and mortality. Conventional treatments with surgery …
Repurposing alpelisib, an anti‐cancer drug, for the treatment of severe TIE2‐mutated venous malformations: Preliminary pharmacokinetics and pharmacodynamic …
Extensive venous malformations involving limbs severely impact quality of life, mostly due to
chronic pain and functional limitations. But patients can also display coagulopathy with …
chronic pain and functional limitations. But patients can also display coagulopathy with …
Targeted therapy for capillary-venous malformations
L Zerbib, S Ladraa, A Fraissenon, C Bayard… - … and Targeted Therapy, 2024 - nature.com
Sporadic venous malformations are genetic conditions primarily caused by somatic gain-of-
function mutation of PIK3CA or TEK, an endothelial transmembrane receptor signaling …
function mutation of PIK3CA or TEK, an endothelial transmembrane receptor signaling …
PIK3CA-Related Disorders: From Disease Mechanism to Evidence-Based Treatments
GM Morin, L Zerbib, S Kaltenbach… - Annual Review of …, 2024 - annualreviews.org
Recent advances in genetic sequencing are transforming our approach to rare-disease
care. Initially identified in cancer, gain-of-function mutations of the PIK3CA gene are also …
care. Initially identified in cancer, gain-of-function mutations of the PIK3CA gene are also …